HQL - Tekla Life Sciences Investors

NYSE - NYSE Delayed Price. Currency in USD
16.51
-0.07 (-0.42%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close16.58
Open16.54
Bid16.52 x 800
Ask16.53 x 1000
Day's Range16.46 - 16.54
52 Week Range13.95 - 18.20
Volume40,959
Avg. Volume83,426
Market Cap375.697M
Beta (3Y Monthly)1.49
PE Ratio (TTM)40.37
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.48 (9.10%)
Ex-Dividend Date2019-08-27
1y Target EstN/A
  • MoneyShow

    Top Picks 2019- Tekla Life Sciences Investors HQL

    For more conservative investors, my top income pick for the coming year is Tekla Life Sciences Investors (HQL), a closed-end fund, explains Nate Pile, editor of Nate's Notes and a specialist in healthcare and biotechnology stocks.

  • We're sorry this is all we were able to find about this topic.